Order Article Reprints

Sun T, Katenka N, Kogut S, Bratberg J, Rich J, Buchanan A. Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology. 2022; 1(3):101-112. https://doi.org/10.3390/pharma1030010

Sun, Tianyu, Natallia Katenka, Stephen Kogut, Jeffrey Bratberg, Josiah Rich, and Ashley Buchanan. 2022. "Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States" Pharmacoepidemiology 1, no. 3: 101-112. https://doi.org/10.3390/pharma1030010

Sun, T., Katenka, N., Kogut, S., Bratberg, J., Rich, J., & Buchanan, A. (2022). Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology, 1(3), 101-112. https://doi.org/10.3390/pharma1030010